ReviewFrontiers in digital health2025
Autonomous chest x-ray image classification, capabilities and prospects: rapid evidence assessment.
Review in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Screening methods are essential for detection of numerous pathologies. Chest x-ray radiography (CXR) is the most widely used screening modality. During the screening, radiologists primarily examine normal radiographs, which results in a substantial workload and an increased risk of errors. There is an increasing necessity to automate radiological screening in order to facilitate the autonomous sorting of normal studies. Objective: We aimed to evaluate the capabilities of artificial intelligence (AI) techniques for the autonomous CXRs triage and to assess their potential for integration into routine clinical workflow. Methods: A rapid evidence assessment methodology was employed to conduct this review. Literature searches were performed using relevant keywords across PubMed, arXiv, medRxiv, Elibrary, and Google Scholar covering the period from 2019 to 2025. Inclusion criteria comprised large-scale studies addressing multiple pathologies and providing abstracts in English. Meta-analysis was conducted using confusion matrices derived from reported diagnostic performance metrics in the selected studies. Methodological quality and the overall quality of evidence were assessed using a combination of QUADAS-2, QUADAS-CAD, and GRADE frameworks. Results: Out of 327 records, 11 studies met the inclusion criteria. Among these, three studies analyzed datasets reflecting the real-world prevalence of pathologies. Three studies included very large cohorts exceeding 500,000 CXRs, whereas the remaining studies used considerably smaller samples. The proportion of autonomously triaged CXRs ranged from 15.0% to 99.8%, with a weighted average of 42.3% across all publications. Notably, in a study conducted under real-world clinical conditions on continuous data flow, this proportion was 54.8%. Sensitivity was 97.8% (95% CI: 94.8%-99.1%), and specificity was 94.8% (95% CI: 53.0%-99.7%). Fifty-five percent of the studies were classified as having a low risk of bias. Primarily, elevated risk of bias and heterogeneity of results were attributed to variability in sample selection criteria and reference standard evaluation. Conclusions: Modern AI systems for autonomous triage of CXRs are ready to be implemented in clinical practice. AI-driven screening can reduce radiologists' workload, decrease sorting errors and lower the costs associated with screening programs. However, implementation is often hindered by regulatory and legislative barriers. Consequently, comprehensive clinical trials conducted under real-world conditions remain scarce.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.